Answer
The safety and efficacy of Imlygic (talimogene laherparepvec) have not been established in children.
Sources for this answer
- ImlygicAmgen Ltd · emc · SmPC §4.2 Posology and method of administration · Version 14Document updated
Sources checked
loading page…